Contemporary rates of severe hypoglycaemia in youth with Type1 diabetes: Variability by insulin regimen

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages 926-932

  Katz, M L ^a   Volkening, L K ^a   Anderson, B J ^b   Laffel, L M ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hypoglycaemia; Insulin therapy; Paediatrics; Type1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE;

ADOLESCENT; ARTICLE; BIVARIATE ANALYSIS; CHILD; COMA; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; SCHOOL CHILD; SEIZURE;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; COGNITION DISORDERS; COMA; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN, LONG-ACTING; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 84862670372     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03646.x     Document Type: Article

References (30)

1. Haugstvedt A, Wentzel-Larsen T, Graue M, Sovik O, Rokne B. Fear of hypoglycaemia in mothers and fathers of children with Type1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 2010; 27: 72-78.
2. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA. Neuropsychological profiles of children with type1 diabetes 6years after disease onset. Diabetes Care 2001; 24: 1541-1546.
3. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child 1999; 81: 318-323.
4. Aye T, Reiss AL, Kesler S, Hoang S, Drobny J, Park Y et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type1 diabetes in young children. Diabetes Care 2011; 34: 1458-1462.
5. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
6. Wood JR, Laffel LMB. Technology and intensive management in youth with type1 diabetes: state of the art. Curr Diab Rep 2007; 7: 104-113.
7. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2, 873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes. Diabetes Care 1997; 20: 714-720.
8. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O et al. Factors associated with glycemic control. A cross-sectional nationwide study in 2, 579 French children with type1 diabetes. The French Pediatric Diabetes Group. Diabetes Care 1998; 21: 1146-1153.
9. Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type1 diabetes. Diabetes Care 2004; 27: 2293-2298.
10. Braun D, Konrad D, Lang-Muritano M, Schoenle E. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type1 diabetes. Pediatr Diabetes 2008; 9: 382-387.
11. Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LMB. Temporal trends in the treatment of pediatric type1 diabetes and impact on acute outcomes. J Pediatr 2007; 150: 279-285.
12. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M et al. Predictors of acute complications in children with type1 diabetes. J Am Med Assoc 2002; 287: 2511-2518.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29: S43-S48.
14. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90: 450-459.
15. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.
16. Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005; 6: 193-198.
17. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pankowska E, Ludvigsson J et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 2008; 51: 1594-1601.
18. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17-22.
19. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type1 diabetes. N Engl J Med 2008; 359: 1464-1476.
20. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type1 diabetes. Diabetes Care 2011; 34: 795-800.
21. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN et al. Effectiveness of sensor-augmented insulin-pump therapy in type1 diabetes. N Engl J Med 2010; 363: 311-320.
22. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of severe hypoglycemia in type1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care 2011; 34: 586-590.
23. Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type1 diabetes. A meta-analysis. Diabetes Obes Metab 2009; 11: 372-378.
24. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009; 94: 729-740.
25. Streisand R, Swift E, Wickmark T, Chen R, Holmes CS. Pediatric parenting stress among parents of children with type1 diabetes: the role of self-efficacy, responsibility, and fear. J Pediatr Psychol 2005; 30: 513-521.
26. Clarke WL, Gonder-Frederick A, Snyder AL, Cox DJ. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998; 11: S189-S194.
27. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005; 28: 726-735.
28. Paris CA, Imperatore G, Klingensmith G, Petitti D, Rodriguez B, Anderson AM et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr 2009; 155: 183-189.
29. Levine BS, Anderson BJ, Butler DA, Brackett J, Laffel L. Predictors of glycemic control and short-term adverse outcomes in youth with type1 diabetes. J Pediatr 2001; 139: 197-203.
30. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994; 43: 1378-1389.